EUVIMEDEUVIMED entdecken
Leserbrief

Development of VIII inhibitors beyond 50 exposure days to rFVIII during prophylactic emicizumab therapy

Yuichi Mitani iD, Mamoru Honda, Yoshitaka Mizushima, Makiko Mori, Kohei Fukuoka, Koichi Oshima, Yuki Arakawa, Katsuaki Taira, Yutaka Tanami, Katsuyoshi Koh

Haemophilia · 2023

DOI: 10.1111/hae.14854 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Haemophilia, 2023. Verfasst von Yuichi Mitani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Hemophilia A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificHemophilia AHumansFactor VIIIAntibodies, Monoclonal, Humanized

Substanzen

emicizumabFactor VIIIAntibodies, BispecificAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Department of Orthopedic Surgery, Saitama Children's Medical Center, Saitama, Japan.
  • Department of Radiology, Saitama Children's Medical Center, Saitama, Japan.

ORCID-Profile: Yuichi Mitani

Zitieren

APA

Mitani, Y., Honda, M., Mizushima, Y., Mori, M., Fukuoka, K., Oshima, K., Arakawa, Y., Taira, K., Tanami, Y., & Koh, K. (2023). Development of VIII inhibitors beyond 50 exposure days to rFVIII during prophylactic emicizumab therapy. Haemophilia. https://doi.org/10.1111/hae.14854

Vancouver

Mitani Y, Honda M, Mizushima Y, Mori M, Fukuoka K, Oshima K, et al. Development of VIII inhibitors beyond 50 exposure days to rFVIII during prophylactic emicizumab therapy. Haemophilia. 2023. doi:10.1111/hae.14854

BibTeX
@article{Mitani2023,
  author = {Mitani, Yuichi and Honda, Mamoru and Mizushima, Yoshitaka and Mori, Makiko and Fukuoka, Kohei and Oshima, Koichi and Arakawa, Yuki and Taira, Katsuaki and Tanami, Yutaka and Koh, Katsuyoshi},
  title = {Development of VIII inhibitors beyond 50 exposure days to rFVIII during prophylactic emicizumab therapy},
  journal = {Haemophilia},
  year = {2023},
  doi = {10.1111/hae.14854}
}
Kostenlos starten →